What is Reflect Scientfc's earnings per share (EPS)?

Reflect Scientfc (RSCF) reported diluted earnings per share of -$0.01 for fiscal year 2023. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Reflect Scientfc Financials

RSCF

FY2023 annual

Revenue $1.1M -47.1% YoY

Net Income -$459K -613.5% YoY

EPS (Diluted) -$0.01 YoY not available

Free Cash Flow Not reported for FY2023

Source SEC Filings (10-K/10-Q) Data as of Sep 30, 2024 Currency USD FYE December

Reflect Scientfc (RSCF) reported $1.1M in revenue for fiscal year 2023, down 47.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI RSCF FY2023 2026-08-15

Reflect Scientific’s profits are highly volume-sensitive, with sales swings translating into much larger moves in operating results and cash use.

From FY2021 to FY2023, revenue fell from $2.8M to $1.1M, showing that scale rather than product economics was the main moving part. Gross margin was still 55.2% in FY2023, yet operating margin dropped to -43.3%; that gap, alongside rising inventory as sales weakened, points to fixed-cost absorption and cash getting stuck in stock.

The balance sheet is still liquid: cash of $1.3M and a current ratio of 4.0x indicate near-term obligations can be met from existing resources. But total liabilities climbed to $776K, so the business is leaning more on its cash cushion than on current operations.

Working capital moved in the wrong direction for a slowdown. Receivables fell to $108K while inventory rose to $972K, a sign that cash is tied up in unsold product rather than being pulled forward by stronger customer demand.

Financial Health Signals

Financial health score not available

Reflect Scientfc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-6.48

Reflect Scientfc scores -6.48, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($3.9M) relative to total liabilities ($776K). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

1/8

Reflect Scientfc passes 1 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality No Cash Backing

N/A

Reflect Scientfc reported a net loss of $459K while operations used $104K of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.1M

YoY-47.1%

5Y CAGR-7.0%

10Y CAGR-1.7%

Reflect Scientfc generated $1.1M in revenue in fiscal year 2023. This represents a decrease of 47.1% from the prior year.

Net Income

-$459K

YoY-613.5%

Reflect Scientfc reported -$459K in net income in fiscal year 2023. This represents a decrease of 613.5% from the prior year.

EPS (Diluted)

-$0.01

Reflect Scientfc earned -$0.01 per diluted share (EPS) in fiscal year 2023.

EBITDA

Not reported for fiscal year 2023.

Cash & Balance Sheet

Cash & Debt

$1.3M

YoY-7.5%

5Y CAGR+42.1%

10Y CAGR+17.7%

Reflect Scientfc held $1.3M in cash as of fiscal year 2023; long-term debt is not reported for that period.

Shares Outstanding

86M

YoY+0.5%

5Y CAGR+1.6%

10Y CAGR+4.8%

Reflect Scientfc had 86M shares outstanding in fiscal year 2023. This represents an increase of 0.5% from the prior year.

Free Cash Flow

Not reported for fiscal year 2023.

Dividends Per Share

Not reported for fiscal year 2023.

Margins & Returns

Gross Margin

55.2%

YoY-4.5pp

5Y CAGR-13.4pp

10Y CAGR+3.2pp

Reflect Scientfc's gross margin was 55.2% in fiscal year 2023, indicating the percentage of revenue retained after direct costs. This is down 4.5 percentage points from the prior year.

Operating Margin

-43.3%

YoY-47.7pp

5Y CAGR-27.2pp

10Y CAGR+26.6pp

Reflect Scientfc's operating margin was -43.3% in fiscal year 2023, reflecting core business profitability. This is down 47.7 percentage points from the prior year.

Net Margin

-42.5%

YoY-46.9pp

5Y CAGR-26.4pp

10Y CAGR+36.2pp

Reflect Scientfc's net profit margin was -42.5% in fiscal year 2023, showing the share of revenue converted to profit. This is down 46.9 percentage points from the prior year.

Return on Equity

-24.3%

YoY-28.1pp

5Y CAGR+20.9pp

Reflect Scientfc's ROE was -24.3% in fiscal year 2023, measuring profit generated per dollar of shareholder equity. This is down 28.1 percentage points from the prior year.

Capital Allocation

R&D Spending

$30K

YoY-59.8%

5Y CAGR-22.3%

10Y CAGR-2.3%

Reflect Scientfc invested $30K in research and development in fiscal year 2023. This represents a decrease of 59.8% from the prior year.

Share Buybacks

Not reported for fiscal year 2023.

Capital Expenditures

Not reported for fiscal year 2023.

RSCF Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

RSCF annual income statement

Metric	TTM	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Revenue	$1.7M	$1.1M-47.1%	$2.0M-27.5%	$2.8M+0.8%	$2.8M+73.5%	$1.6M+3.7%	$1.6M+45.6%	$1.1M-10.3%	$1.2M+14.6%	$1.0M-32.1%	$1.5M+18.7%	$1.3M-3.2%	$1.3M-33.1%	$2.0M-17.3%	$2.4M
Cost of Revenue	$715K	$484K-41.2%	$822K-7.0%	$884K-17.5%	$1.1M+73.5%	$618K+26.8%	$487K+20.0%	$406K+7.9%	$376K-7.6%	$407K-40.0%	$678K+9.7%	$618K0.0%	$618K-37.6%	$989K-24.6%	$1.3M
Gross Profit	$1.0M	$596K-51.1%	$1.2M-36.9%	$1.9M+12.2%	$1.7M+73.6%	$992K-6.9%	$1.1M+61.4%	$660K-18.8%	$813K+28.9%	$630K-25.8%	$850K+27.0%	$669K-5.9%	$711K-28.7%	$998K-8.4%	$1.1M
R&D Expenses	$24K	$30K-59.8%	$73K+25.9%	$58K-68.5%	$185K-11.8%	$210K+101.8%	$104K+122.8%	$47K-34.0%	$71K-2.8%	$73K+229.2%	$22K-40.4%	$37K+3.4%	$36K+8.4%	$33K+335.4%	$8K
SG&A Expenses	$443K	$389K-7.4%	$420K-3.9%	$436K+24.5%	$350K-14.2%	$408K-34.6%	$624K+90.0%	$328K-3.7%	$341K+6.2%	$321K-53.1%	$684K+7.2%	$639K-2.0%	$651K-29.6%	$925K+23.6%	$748K
Operating Income	-$62K	-$467K-618.6%	$90K-89.1%	$828K+27.2%	$651K+434.1%	-$195K+21.7%	-$249K+38.1%	-$402K-59.9%	-$252K+45.3%	-$460K+36.0%	-$719K+20.0%	-$899K+69.1%	-$2.9M-311.9%	-$707K-693.4%	-$89K
Interest Expense	N/A	N/A	N/A	N/A	$890+217.9%	-$755-14.2%	-$661	$0+100.0%	-$314+99.5%	-$59K+51.7%	-$123K-4.3%	-$118K-137.4%	$316K-40.9%	$534K-0.2%	$535K
Income Tax	N/A	$312-55.6%	$702	N/A	N/A	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	-$29K	-$459K-613.5%	$89K-90.5%	$939K+42.3%	$660K+437.5%	-$196K+21.6%	-$250K+38.0%	-$402K-86.0%	-$216K-125.9%	$836K+199.4%	-$841K+17.0%	-$1.0M-604.3%	$201K+116.9%	-$1.2M+33.0%	-$1.8M
EPS (Diluted)	—	-$0.01	$0.00-100.0%	$0.010.0%	$0.01	N/A	$0.00+100.0%	-$0.01	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22
Revenue	$514K-12.9%	$590K+37.6%	$429K+127.1%	$189K-64.1%	$526K+322.8%	$124K-48.4%	$241K-49.6%	$479K
Cost of Revenue	$186K-19.6%	$232K+23.8%	$187K+69.4%	$110K-43.7%	$196K+206.8%	$64K-43.8%	$114K-57.9%	$270K
Gross Profit	$328K-8.6%	$359K+48.3%	$242K+208.4%	$78K-76.2%	$330K+445.1%	$61K-52.5%	$127K-39.0%	$209K
R&D Expenses	$3K-32.9%	$5K-37.6%	$7K-18.2%	$9K-0.7%	$9K+68.8%	$5K-11.3%	$6K-59.4%	$15K
SG&A Expenses	$88K-18.6%	$108K-18.7%	$132K+14.1%	$116K+37.5%	$84K+3.7%	$81K-24.0%	$107K+3.0%	$104K
Operating Income	$99K+0.9%	$98K+342.8%	-$41K+81.6%	-$220K-371.4%	$81K+144.7%	-$181K-22.3%	-$148K-141.1%	-$61K
Interest Expense	N/A	$11K	N/A	N/A	N/A	-$312	N/A	N/A
Income Tax	$100	N/A	N/A	N/A	N/A	$312	N/A	N/A
Net Income	$110K+0.9%	$109K+440.9%	-$32K+85.2%	-$216K-350.8%	$86K+147.6%	-$181K-22.5%	-$148K-141.1%	-$61K
EPS (Diluted)	$0.00	$0.00	$0.00	N/A	$0.00	$0.00	$0.00	N/A

TTM is the trailing twelve months, Q4 FY2023 through Q3 FY2024, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

RSCF Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

RSCF annual balance sheet

Metric	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Total Assets	$2.7M+9.1%	$2.4M-1.3%	$2.5M+47.9%	$1.7M	N/A	$1.1M+82.0%	$593K+2.2%	$580K-17.9%	$706K-16.2%	$843K-1.7%	$858K-35.1%	$1.3M-67.9%	$4.1M-9.3%	$4.5M
Current Assets	$2.4M+1.8%	$2.3M+1.0%	$2.3M+59.5%	$1.4M	N/A	$954K+82.8%	$522K+1.0%	$517K-19.0%	$638K-14.5%	$746K+3.6%	$720K-17.4%	$872K-1.6%	$886K+1.9%	$870K
Cash & Equivalents	$1.3M-7.5%	$1.4M-6.2%	$1.5M+129.4%	$643K+15.7%	$555K+151.9%	$220K-6.5%	$236K-10.6%	$264K-9.6%	$292K+7.8%	$271K+7.8%	$251K-3.5%	$261K-24.8%	$347K+43.2%	$242K
Inventory	$972K+21.9%	$797K+27.7%	$624K+42.4%	$439K	N/A	$253K+77.7%	$142K-8.4%	$155K-24.7%	$206K-4.4%	$216K-31.0%	$313K-14.3%	$365K-7.0%	$393K+4.3%	$377K
Accounts Receivable	$108K-16.3%	$129K-26.4%	$176K-48.4%	$340K	N/A	$118K-23.8%	$156K+27.0%	$122K-10.2%	$136K-46.8%	$256K+67.9%	$153K+9.0%	$140K-2.3%	$143K-41.1%	$243K
Goodwill	$60K0.0%	$60K0.0%	$60K0.0%	$60K	N/A	$60K0.0%	$60K0.0%	$60K0.0%	$60K0.0%	$60K0.0%	$60K-81.6%	$326K-50.0%	$652K0.0%	$652K
Total Liabilities	$776K+419.0%	$150K-50.0%	$299K-35.4%	$463K	N/A	$526K+601.7%	$75K-39.8%	$124K-18.0%	$152K-89.2%	$1.4M+3.9%	$1.4M+5.5%	$1.3M-71.3%	$4.5M+9.3%	$4.1M
Current Liabilities	$596K+298.7%	$150K-38.1%	$242K-0.3%	$243K	N/A	$513K+584.9%	$75K-39.8%	$124K-18.0%	$152K-89.2%	$1.4M+3.9%	$1.4M+5.5%	$1.3M-71.3%	$4.5M+9.3%	$4.1M
Total Equity	$1.9M-17.6%	$2.3M+5.4%	$2.2M+79.7%	$1.2M+119.4%	$553K0.0%	$553K+6.8%	$518K+13.7%	$455K-17.9%	$555K+197.9%	-$567K-13.5%	-$499K-1482.1%	$36K+110.1%	-$358K-180.0%	$447K
Retained Earnings	-$19.3M-2.4%	-$18.8M+0.5%	-$18.9M+4.7%	-$19.8M+3.2%	-$20.5M0.0%	-$20.5M-1.0%	-$20.3M-1.2%	-$20.1M-3.2%	-$19.4M+4.1%	-$20.3M-4.3%	-$19.4M-5.5%	-$18.4M+1.1%	-$18.6M-6.8%	-$17.4M

Metric	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22
Total Assets	$2.3M+0.5%	$2.3M-13.1%	$2.7M+0.3%	$2.7M-1.4%	$2.7M+8.7%	$2.5M+9.9%	$2.3M-7.3%	$2.4M
Current Assets	$2.1M+1.4%	$2.1M-13.9%	$2.4M+1.1%	$2.4M-0.8%	$2.4M-0.5%	$2.4M+11.0%	$2.2M-7.1%	$2.3M
Cash & Equivalents	$1.0M-6.6%	$1.1M+0.3%	$1.1M-14.0%	$1.3M-4.6%	$1.3M-4.9%	$1.4M+17.5%	$1.2M-13.2%	$1.4M
Inventory	$776K-7.2%	$836K-12.1%	$951K-2.2%	$972K+5.6%	$921K+5.0%	$877K+3.1%	$851K+6.7%	$797K
Accounts Receivable	$272K+146.0%	$111K-67.0%	$335K+209.6%	$108K-10.0%	$120K+29.6%	$93K-14.4%	$108K-16.2%	$129K
Goodwill	$60K0.0%	$60K0.0%	$60K0.0%	$60K0.0%	$60K0.0%	$60K0.0%	$60K0.0%	$60K
Total Liabilities	$259K-27.6%	$357K-56.3%	$816K+5.1%	$776K+22.9%	$632K+24.1%	$509K+357.7%	$111K-25.6%	$150K
Current Liabilities	$139K-35.6%	$216K-67.0%	$655K+9.9%	$596K+37.3%	$434K-14.7%	$509K+357.7%	$111K-25.6%	$150K
Total Equity	$2.1M+5.6%	$2.0M+5.9%	$1.9M-1.7%	$1.9M-8.8%	$2.1M+4.7%	$2.0M-8.1%	$2.2M-6.1%	$2.3M
Retained Earnings	-$19.1M+0.6%	-$19.2M+0.6%	-$19.3M-0.2%	-$19.3M-1.1%	-$19.1M+0.5%	-$19.1M-1.0%	-$19.0M-0.8%	-$18.8M

Not reported in any period shown, so not listed: Long-Term Debt.

RSCF Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

RSCF annual cash flow statement

Metric	TTM	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Operating Cash Flow	-$309K	-$104K-13.0%	-$92K-111.1%	$831K+3396.8%	-$25K-107.5%	$336K+2407.0%	-$15K+48.2%	-$28K-50.1%	-$19K-158.7%	$32K-70.9%	$110K+297.5%	-$56K+39.0%	-$91K-169.9%	$130K-33.5%	$196K
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	$0+100.0%	-$11K	$0	$0	$0	$0-100.0%	$51K	$0	$0+100.0%	-$100K
Financing Cash Flow	N/A	N/A	N/A	N/A	$113K+9977.5%	-$1K-111.5%	$10K	$0+100.0%	-$9K+13.6%	-$11K+87.9%	-$90K-2055.5%	-$4K-183.9%	$5K+119.4%	-$26K-31.6%	-$20K

Metric	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22
Operating Cash Flow	-$72K-2309.3%	$3K+101.8%	-$179K-190.3%	-$61K+11.3%	-$69K-133.1%	$210K+214.7%	-$183K-419.6%	$57K

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

RSCF Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

RSCF annual financial ratios

Metric	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Gross Margin	55.2%-4.5pp	59.7%-8.9pp	68.6%+7.0pp	61.6%0.0pp	61.6%-7.0pp	68.6%+6.7pp	61.9%-6.5pp	68.4%+7.6pp	60.8%+5.1pp	55.6%+3.6pp	52.0%-1.5pp	53.5%+3.3pp	50.2%+4.8pp	45.4%
Operating Margin	-43.3%-47.7pp	4.4%-25.0pp	29.4%+6.1pp	23.3%+35.4pp	-12.1%+3.9pp	-16.0%+21.7pp	-37.7%-16.6pp	-21.2%+23.2pp	-44.3%+2.7pp	-47.0%+22.8pp	-69.8%	-219.1%	-35.6%-31.9pp	-3.7%
Net Margin	-42.5%-46.9pp	4.4%-29.0pp	33.4%+9.7pp	23.6%+35.8pp	-12.2%+3.9pp	-16.1%+21.7pp	-37.7%-19.6pp	-18.2%-98.8pp	80.6%+135.6pp	-55.0%+23.7pp	-78.7%-93.8pp	15.1%+74.9pp	-59.7%+14.1pp	-73.8%
Return on Equity	-24.3%-28.1pp	3.9%-39.2pp	43.1%-11.3pp	54.4%+89.8pp	-35.4%+9.7pp	-45.1%+32.6pp	-77.7%-30.2pp	-47.5%-198.2pp	150.7%	N/A	N/A	556.1%	N/A	-396.4%
Return on Assets	-17.2%-20.8pp	3.6%-34.2pp	37.9%-1.5pp	39.4%	N/A	-23.1%+44.7pp	-67.9%-30.6pp	-37.3%-155.6pp	118.3%+218.0pp	-99.7%+18.4pp	-118.1%-133.3pp	15.2%+44.0pp	-28.8%+10.2pp	-39.0%
Current Ratio	3.97-11.6x	15.57+6.0x	9.53+3.6x	5.96	N/A	1.86-5.1x	6.96+2.8x	4.15-0.1x	4.21+3.7x	0.530.0x	0.53-0.1x	0.68+0.5x	0.200.0x	0.21
Debt-to-Equity	0.41+0.3x	0.07-0.1x	0.14-0.2x	0.38	N/A	0.95+0.8x	0.14-0.1x	0.270.0x	0.27	N/A	N/A	35.61	N/A	9.17

Metric	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22
Gross Margin	63.8%+3.0pp	60.8%+4.4pp	56.4%+14.8pp	41.5%-21.2pp	62.7%+14.1pp	48.7%-4.2pp	52.9%+9.2pp	43.6%
Operating Margin	19.3%+2.6pp	16.7%+26.1pp	-9.4%	-116.3%	15.4%	-145.3%	-61.3%-48.5pp	-12.8%
Net Margin	21.4%+2.9pp	18.5%+25.9pp	-7.5%	-114.6%	16.4%	-145.6%	-61.3%-48.5pp	-12.8%
Return on Equity	5.3%-0.2pp	5.5%+7.3pp	-1.7%+9.7pp	-11.4%-15.6pp	4.2%+13.3pp	-9.1%-2.3pp	-6.9%-4.2pp	-2.7%
Return on Assets	4.7%0.0pp	4.7%+5.9pp	-1.2%+6.9pp	-8.1%-11.3pp	3.2%+10.5pp	-7.3%-0.8pp	-6.5%-4.0pp	-2.5%
Current Ratio	15.03+5.5x	9.55+5.9x	3.66-0.3x	3.97-1.5x	5.50+0.8x	4.72-14.7x	19.45+3.9x	15.57
Debt-to-Equity	0.12-0.1x	0.18-0.3x	0.440.0x	0.41+0.1x	0.300.0x	0.26+0.2x	0.050.0x	0.07

Not reported in any period shown, so not listed: FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin.

Similar Companies

Encision ECIA

$739K

Cardiac Biotech Solutions Inc CBSC

$6.8M

Cecors Inc CEOS

$2.2M

United Health Pr UEEC

$10.0M

Wearable Health WHSI

$183K

Where Reflect Scientfc Ranks

Frequently Asked Questions

What is Reflect Scientfc's annual revenue?

Reflect Scientfc (RSCF) reported $1.1M in total revenue for fiscal year 2023. This represents a -47.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Reflect Scientfc's revenue growing?

Reflect Scientfc (RSCF) revenue declined by 47.1% year-over-year, from $2.0M to $1.1M in fiscal year 2023.

Is Reflect Scientfc profitable?

No, Reflect Scientfc (RSCF) reported a net income of -$459K in fiscal year 2023, with a net profit margin of -42.5%.

What is Reflect Scientfc's gross margin?

Reflect Scientfc (RSCF) had a gross margin of 55.2% in fiscal year 2023, indicating the percentage of revenue retained after direct costs of goods sold.

What is Reflect Scientfc's operating margin?

Reflect Scientfc (RSCF) had an operating margin of -43.3% in fiscal year 2023, reflecting the profitability of core business operations before interest and taxes.

What is Reflect Scientfc's net profit margin?

Reflect Scientfc (RSCF) had a net profit margin of -42.5% in fiscal year 2023, representing the share of revenue converted into profit after all expenses.

What is Reflect Scientfc's return on equity (ROE)?

Reflect Scientfc (RSCF) has a return on equity of -24.3% for fiscal year 2023, measuring how efficiently the company generates profit from shareholder equity.

What is Reflect Scientfc's operating cash flow?

Reflect Scientfc (RSCF) recorded an outflow of $104K in operating cash flow during fiscal year 2023, representing cash used by core business activities.

What are Reflect Scientfc's total assets?

Reflect Scientfc (RSCF) had $2.7M in total assets as of fiscal year 2023, including both current and long-term assets.

How much does Reflect Scientfc spend on research and development?

Reflect Scientfc (RSCF) invested $30K in research and development during fiscal year 2023.

How many shares does Reflect Scientfc have outstanding?

Reflect Scientfc (RSCF) had 86M shares outstanding as of fiscal year 2023.

What is Reflect Scientfc's current ratio?

Reflect Scientfc (RSCF) had a current ratio of 3.97 as of fiscal year 2023, which is generally considered healthy.

What is Reflect Scientfc's debt-to-equity ratio?

Reflect Scientfc (RSCF) had a debt-to-equity ratio of 0.41 as of fiscal year 2023, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Reflect Scientfc's return on assets (ROA)?

Reflect Scientfc (RSCF) had a return on assets of -17.2% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.

What is Reflect Scientfc's Altman Z-Score?

Reflect Scientfc (RSCF) has an Altman Z-Score of -6.48, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Reflect Scientfc's Piotroski F-Score?

Reflect Scientfc (RSCF) has a Piotroski F-Score of 1 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Reflect Scientfc's earnings high quality?

Reflect Scientfc (RSCF) reported a net loss of $459K while operations used $104K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.